ConductScience.org, home

Gene · 51135

NIH grants2,116

NIH grants whose papers are about the gene, through NIH's grant-paper links.

181 to 200 of 2,116

Download this page as JSON
GrantTitleIRAK4 papersNewest fiscal year
R01AI140442Betacoronaviruses: activation and antagonism of host innate immune responses12025
R01AI155425Implicating a previously unknown Dectin1-RIPK2-CARD9 signaling in providing resistance against Leishmania major infection12025
R01AI155545Anti-inflammatory functions for non-transcriptional IRF312025
R01AI155653Mechanisms of B cell responses to particulate antigens12025
R01AI155749MDS-Associated Spliceosome Mutations Regulate Host Defense12025
R01AI156268Chemoproteomic-Enabled Strategy to Study SLC Transporter Roles in Inflammation12025
R01AI157353Host Immunity in Sepsis-Induced Systemic Infection12025
R01AI161444Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo12025
R01AI161570Broad-spectrum therapeutics against SARS-CoV-2 3CL protease12025
R01AI165521Novel antiviral mechanisms of the interferon system12025
R01AI165922DNA induction of neutrophilic asthma12025
R01AI168005Staphylococcus aureus induced itch and neuro-immune signaling in skin infections12025
R01AI171980Function of T cells at the Maternal-Fetal Interface12025
R01AR046713Cytokine regulation of RA synoviocyte phenotype12025
R01AR050401Cytokine Balance in Rheumatoid Arthritis12025
R01AR062173The IL-23/IL-17 Axis in Inflammatory Arthritis12025
R01AR070736Uncovering the role of Setbp1 in fibroblast-like synoviocytes during inflammatory arthritis12025
R01AR075813Impact of Loss-of-function NADPH Oxidase Variants on B cell Activation in SLE12025
R01CA104509Molecular Mechanism of Leukemogenesis involving AML1-ETO12025
R01CA152108Molecular and Cellular Mechanisms of Chronic Myelomonocytic Leukemia (CMML)12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/51135/grants?page=10